IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 51 a 100 di 195
Titolo Data di pubblicazione Autore(i) File
Re: Friederike Haidl, David Pfister, Axel Heidenreich. Re: Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. Mordasini L, Hechelhammer L, Diener PA, et al. J Vasc Interv Radiol 2018;29:589–97. Eur Urol 2018;74:525–6: Could Morphologic Changes in Periprostatic Arteries Have an Influence on Prostatic Artery Embolization? 1-gen-2019 Cimadamore, A.; Scarpelli, M.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
OUTCOMES OF DIFFERENT PATTERN OF SEMINAL VESICLE INVASION IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY 1-gen-2019 Montesi, L; Palagonia, E; Leone, L; Capretti, C; Cimadamore, A; Dell'Atti, L; Galosi, Ab; Montironi, R
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion 1-gen-2019 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer 1-gen-2019 Blanca, A.; Sanchez-Gonzalez, A.; Requena, M. J.; Carrasco-Valiente, J.; Gomez-Gomez, E.; Cheng, L.; Cimadamore, A.; Montironi, R.; Lopez-Beltran, A.
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 1-gen-2019 Gasparrini, S.; Cimadamore, A.; Scarpelli, M.; Massari, F.; Doria, A.; Mazzucchelli, R.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer 1-gen-2019 Mollica, Veronica; Di Nunno, Vincenzo; Cimadamore, Alessia; Lopez-Beltran, Antonio; Cheng, Liang; Santoni, Matteo; Scarpelli, Marina; Montironi, Rodolfo; Massari, Francesco
Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule 1-gen-2019 Vau, N.; Henriques, V.; Cheng, L.; Blanca, A.; Fonseca, J.; Montironi, R.; Cimadamore, A.; Lopez-Beltran, A.
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 1-gen-2019 Santoni, Matteo; Heng, Daniel Yc; Aurilio, Gaetano; Iozzelli, Andrea; Servi, Lucilla; Fabiani, Andrea; Giannini, Massimo; Mazzucchelli, Roberta; Cimadamore, Alessia; Scarpelli, Marina; Zaghloul, Mohamed S; Battelli, Nicola; Montironi, Rodolfo
Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2? 1-gen-2019 Montironi, R.; Cheng, L.; Cimadamore, A.; Lopez-Beltran, A.
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution 1-gen-2019 Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Pisconti, S.; Battelli, N.; Massari, F.
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples 1-gen-2019 Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A.
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 1-gen-2019 Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Scarpelli, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.; Massari, F.
Pathology of the benign and malignant diseases of the prostate 1-gen-2020 Montironi, R; Mazzucchelli, R; Cimadamore, A; Scarpelli, M; Lopez-Beltran, A; Cheng, L
Targeted treatment of renal cell carcinoma 1-gen-2020 Santoni, M; Cimadamore, A; Cheng, L; Lopez-Beltran, A; Scarpelli, M; Battelli, N; Montironi, R.
Surgical pathology of cystic renal cell carcinomas: is there an overestimation of malignancy? 1-gen-2020 Paner, G. P.; Cimadamore, A.; Darrell, C. M.; Tretiakova, M. S.; Montironi, R.
Update on circulating tumor cells in genitourinary tumors with focus on prostate cancer 1-gen-2020 Cimadamore, A.; Aurilio, G.; Nole, F.; Massari, F.; Scarpelli, M.; Santoni, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins 1-gen-2020 Rocco, B.; Sighinolfi, M. C.; Cimadamore, A.; Reggiani Bonetti, L.; Bertoni, L.; Puliatti, S.; Eissa, A.; Spandri, V.; Azzoni, P.; Dinneen, E.; Shaw, G.; Nathan, S.; Micali, S.; Bianchi, G.; Maiorana, A.; Pellacani, G.; Montironi, R.
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 1-gen-2020 Santoni, M.; Heng, D. Y.; Bracarda, S.; Procopio, G.; Milella, M.; Porta, C.; Matrana, M. R.; Carteni, G.; Crabb, S. J.; De Giorgi, U.; Basso, U.; Masini, C.; Calabro, F.; Vitale, M. G.; Santini, D.; Massari, F.; Galli, L.; Fornarini, G.; Ricotta, R.; Buti, S.; Zucali, P.; Caffo, O.; Morelli, F.; Carrozza, F.; Martignetti, A.; Gelibter, A.; Iacovelli, R.; Mosca, A.; Atzori, F.; Vau, N.; Incorvaia, L.; Ortega, C.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Paolucci, V.; Graham, J.; Pierce, E.; Scagliarini, S.; Sepe, P.; Verzoni, E.; Merler, S.; Rizzo, M.; Sorgentoni, G.; Conti, A.; Piva, F.; Cimadamore, A.; Montironi, R.; Battelli, N.
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 1-gen-2020 Cimadamore, A.; Lopez-Beltran, A.; Massari, F.; Santoni, M.; Mazzucchelli, R.; Scarpelli, M.; Galosi, A. B.; Cheng, L.; Montironi, R.
Considerations on current and future issues related to reproducibility and accuracy in prostate cancer grading 1-gen-2020 Montironi, R.; Cimadamore, A.
Re: Lorenzo Marconi, Thomas Stonier, Rafael Tourinho-Barbosa, et al. Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Eur Urol 2019;76:27–30: Morphologic Documentation from Didactic Cases of Large-format Histology 1-gen-2020 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 1-gen-2020 Cantini, L.; Pecci, F.; Murrone, A.; Tomasetti, M.; Copparoni, C.; Fiordoliva, I.; Morgese, F.; Rinaldi, S.; Mazzanti, P.; Rubini, C.; Cimadamore, A.; Barbisan, F.; Giampieri, R.; Scarpelli, M.; Santarelli, L.; Berardi, R.
Digital pathology and COVID-19 and future crises: pathologists can safely diagnose cases from home using a consumer monitor and a mini PC 1-gen-2020 Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Montironi, R.
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer 1-gen-2020 Devlies, Wout; Eckstein, Markus; Cimadamore, Alessia; Devos, Gaëtan; Moris, Lisa; Van den Broeck, Thomas; Montironi, Rodolfo; Joniau, Steven; Claessens, Frank; Gevaert, Thomas
New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents? 1-gen-2020 Aurilio, G.; Cimadamore, A.; Santoni, M.; Nole, F.; Scarpelli, M.; Massari, F.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Liquid biopsy in the clinical management of bladder cancer: current status and future developments 1-gen-2020 Kouba, E.; Lopez-Beltran, A.; Montironi, R.; Massari, F.; Huang, K.; Santoni, M.; Chovanec, M.; Cheng, M.; Scarpelli, M.; Zhang, J.; Cimadamore, A.; Cheng, L.
Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti–PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269–76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation 1-gen-2020 Cimadamore, A.; Cheng, L.; Scarpelli, M.; Lopez-Beltran, A.; Mollica, V.; Montironi, R.; Massari, F.
Uropathologists During the COVID-19 Pandemic: What Can Be Learned in Terms of Social Interaction, Visibility, and Social Distance 1-gen-2020 Montironi, R; Cheng, L; Cimadamore, A; Lopez-Beltran, A; Scarpelli, M
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers 1-gen-2020 Lopez-Beltran, A.; Cheng, L.; Gevaert, T.; Blanca, A.; Cimadamore, A.; Santoni, M.; Massari, F.; Scarpelli, M.; Raspollini, M. R.; Montironi, R.
Immunotherapy for urothelial cancer: from the diagnostic pathologist’s point of view 1-gen-2020 Cimadamore, A.; Scarpelli, M.; Massari, F.; Eckstein, M.; Gevaert, T.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
From undergraduate medical school student to visible pathologist 1-gen-2020 Montironi, R.; Cimadamore, A.; Scarpelli, M.
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 1-gen-2020 Montironi, R.; Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Aurilio, G.; Santoni, M.; Massari, F.; Cheng, L.
PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness 1-gen-2020 Raspollini, M. R.; Montagnani, I.; Cirri, P.; Baroni, G.; Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Barnea, E. R.
Pd-l1 inhibitors for the treatment of prostate cancer 1-gen-2020 Santoni, M.; Massari, F.; Cheng, L.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Lopez-Beltran, A.
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 1-gen-2020 Mollica, V.; Di Nunno, V.; Santoni, M.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Mariani, C.; Battelli, N.; Montironi, R.; Massari, F.
Renal Cell Carcinoma: genomic landscape and clinical implications 1-gen-2020 Aurilio, G.; Santoni, M.; Cimadamore, A.; Massari, F.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Nole, F.; Montironi, R.
pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging 1-gen-2020 Raspollini, M. R.; Montironi, R.; Mazzucchelli, R.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.
Exciting experiences in the 'Rocky road to digital diagnostics' 1-gen-2020 Montironi, R.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.
Predicting future cancer burden in the United States by artificial neural networks 1-gen-2020 Piva, Francesco; Tartari, Francesca; Giulietti, Matteo; Aiello, Marco Maria; Cheng, Liang; Lopez-Beltran, Antonio; Mazzucchelli, Roberta; Cimadamore, Alessia; Cerqueti, Roy; Battelli, Nicola; Montironi, Rodolfo; Santoni, Matteo
Seminal Vesicle Tumor Microenvironment 1-gen-2020 Cimadamore, A.; Montironi, R.; Serni, S.; Campi, R.
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer 1-gen-2020 Saoud, R.; Heidar, N. A.; Cimadamore, A.; Paner, G. P.
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors 1-gen-2020 Mollica, V.; Maggio, I.; Lopez-Beltran, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Rizzo, A.; Giunchi, F.; Schiavina, R.; Fiorentino, M.; Brunocilla, E.; Massari, F.
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives 1-gen-2020 Zong, Y.; Montironi, R.; Massari, F.; Jiang, Z.; Lopez-Beltran, A.; Wheeler, T. M.; Scarpelli, M.; Santoni, M.; Cimadamore, A.; Cheng, L.
Epigenetic modulations and lineage plasticity in advanced prostate cancer 1-gen-2020 Ge, R.; Wang, Z.; Montironi, R.; Jiang, Z.; Cheng, M.; Santoni, M.; Huang, K.; Massari, F.; Lu, X.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.
Real-time assessment of surgical margins during radical prostatectomy: a novel approach that uses fluorescence confocal microscopy for the evaluation of peri-prostatic soft tissue 1-gen-2020 Rocco, B.; Sighinolfi, M. C.; Bertoni, L.; Spandri, V.; Puliatti, S.; Eissa, A.; Reggiani Bonetti, L.; Azzoni, P.; Sandri, M.; De Carne, C.; Turri, F.; Cimadamore, A.; Montironi, R.; Maiorana, A.; Micali, S.; Bianchi, G.; Pellacani, G.
Designing novel immunocombinations in metastatic renal cell carcinoma 1-gen-2020 Santoni, M.; Massari, F.; Aurilio, G.; Mollica, V.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Nole, F.; Montironi, R.
The 1996 European Urology Focus on Preneoplastic Lesions of the Prostate 1-gen-2020 Cimadamore, A.; Montironi, R.
Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsies 1-gen-2020 Cimadamore, A.; Massari, F.; Santoni, M.; Mollica, V.; Di Nunno, V.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.; Moch, H.
Is There a Role for Immunotherapy in Prostate Cancer? 1-gen-2020 Rizzo, A.; Mollica, V.; Cimadamore, A.; Santoni, M.; Scarpelli, M.; Giunchi, F.; Cheng, L.; Lopez-Beltran, A.; Fiorentino, M.; Montironi, R.; Massari, F.
Clinicopathologic analysis of upper urinary tract carcinoma with variant histology 1-gen-2020 Rolim, I.; Henriques, V.; Rolim, N.; Blanca, A.; Marques, R. C.; Volavsek, M.; Carvalho, I.; Montironi, R.; Cimadamore, A.; Raspollini, M. R.; Cheng, L.; Lopez-Beltran, A.
Mostrati risultati da 51 a 100 di 195
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile